Resolvin D1 limits 5-lipoxygenase nuclear localization and leukotriene B4 synthesis by inhibiting a calcium-activated kinase pathway. - Wikidata - awgldk - TriplyDB

Resolvin D1 limits 5-lipoxygenase nuclear localization and leukotriene B4 synthesis by inhibiting a calcium-activated kinase pathway.

Resolvin D1 limits 5-lipoxygenase nuclear localization and leukotriene B4 synthesis by inhibiting a calcium-activated kinase pathway.

http://www.wikidata.org/entity/Q34407602

about

Annexin A1-containing extracellular vesicles and polymeric nanoparticles promote epithelial wound repair.Wound repair: role of immune-epithelial interactions Remodeling of lipid bodies by docosahexaenoic acid in activated microglial cells Recent insights into the cellular biology of atherosclerosis Resolvin D4 stereoassignment and its novel actions in host protection and bacterial clearance.Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function.Lipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney Disease Treatment of Obese Insulin-Resistant Mice With an Allosteric MAPKAPK2/3 Inhibitor Lowers Blood Glucose and Improves Insulin Sensitivity Pro-Resolving Effects of Resolvin D2 in LTD4 and TNF-α Pre-Treated Human Bronchi.Aspirin-triggered resolvin D1 attenuates PDGF-induced vascular smooth muscle cell migration via the cyclic adenosine monophosphate/protein kinase A (cAMP/PKA) pathway.Macrophage Phenotype and Function in Different Stages of Atherosclerosis.MerTK cleavage limits proresolving mediator biosynthesis and exacerbates tissue inflammation.An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques.Calcium signalling and ER stress in insulin resistance and atherosclerosis.Maresin conjugates in tissue regeneration biosynthesis enzymes in human macrophages.Accelerated resolution of inflammation underlies sex differences in inflammatory responses in humans.Resolution of Acute Inflammation and the Role of Resolvins in Immunity, Thrombosis, and Vascular Biology.Cell Death Inducing Microbial Protein Phosphatase Inhibitors--Mechanisms of Action.Boosting Inflammation Resolution in Atherosclerosis: The Next Frontier for Therapy.Specialized pro-resolving mediators in cardiovascular diseases.Human Sepsis Eicosanoid and Proresolving Lipid Mediator Temporal Profiles: Correlations With Survival and Clinical Outcomes.Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice.Activation of autophagy in macrophages by pro-resolving lipid mediators.Peripheral Interaction of Resolvin D1 and E1 with Opioid Receptor Antagonists for Antinociception in Inflammatory Pain in Rats.Discovery of the first dual inhibitor of the 5-lipoxygenase-activating protein and soluble epoxide hydrolase using pharmacophore-based virtual screening MerTK receptor cleavage promotes plaque necrosis and defective resolution in atherosclerosis.Pro-Resolving Mediators in Regulating and Conferring Macrophage Function.Human macrophages differentially produce specific resolvin or leukotriene signals that depend on bacterial pathogenicity.Immunoresolvents signaling molecules at intersection between the brain and immune system.CAMKIIγ suppresses an efferocytosis pathway in macrophages and promotes atherosclerotic plaque necrosis.Inhibition of 5-lipoxygenase alleviates graft-versus-host disease.2016 Russell Ross Memorial Lecture in Vascular Biology: Molecular-Cellular Mechanisms in the Progression of Atherosclerosis.Host Lipid Mediators in Leprosy: The Hypothesized Contributions to Pathogenesis.PDn-3 DPA Pathway Regulates Human Monocyte Differentiation and Macrophage Function.Inflammatory and Pro-resolving Lipids in Trypanosomatid Infections: A Key to Understanding Parasite Control Specialized Pro-Resolving Lipid Mediators in Cystic Fibrosis

P2860

Q24318444-E63904D5-8CA6-415A-A8FD-43819E7B5CF8 Q26801818-24D3939C-ED94-40D4-88CF-5C60CC76B93B Q28395128-D607344C-1949-4726-9C3E-82365965BA64 Q30300194-6AC1CCFF-D75B-412F-AC52-1DDE2B7B7382 Q34508024-56A9EBA7-969B-48B9-AC42-D781F706B791 Q35744344-45F08C3D-74EA-4841-A59F-69654FC0BA5F Q36095550-C8B6612F-5017-443C-A6D8-F73807490D6F Q36104668-80E6DF70-6BB8-4592-A10E-E4B52FC732FA Q36217771-A9CF3F37-8CF2-47A5-854F-09251DAAD035 Q36330155-AF97932D-7260-4840-9F60-3E6728DCDB9F Q36602809-DFF1DB03-ECFA-4290-B7A5-81B2A4A313B5 Q37183630-6E12A78D-6965-4228-8F04-0101CF48AC8D Q37282266-630DB6F9-9DEA-4A04-AF29-CF02CDC196D3 Q37373729-32028D15-3667-483B-9870-4168CE0E71D3 Q37379884-4A5219DE-73F3-4D29-A36E-25D0CDB3718C Q37545061-41DFEB5A-8420-4114-B081-F99F16F15F70 Q37603197-E368F427-3B75-4EB2-9D4C-BD326AE8110F Q38617357-2A0D7827-FB42-497D-B018-FDE99D703A5A Q38681468-AB83060B-485D-48F8-AC8E-2BB6BC67E03E Q39160278-A25F9335-F969-4630-9586-EE4C89292849 Q39385937-BB1896DB-49EC-49C3-AA8D-261C5188ECEC Q39649085-8CF43630-B249-4E93-952B-B1B87DFB0CBD Q39961845-400AFD59-B3E4-4A30-91D0-EF9BED45D66F Q41222249-F7AC00DC-B4D8-4FC2-AD68-79DB4C0EF8AB Q41821577-5FB4D2DD-3ABC-4E45-BD38-8DD3AEA41674 Q42001768-05017133-57E2-4C8D-8390-08B7D68EDCE8 Q47104000-0487C508-0B4F-417D-A988-02A422710505 Q47215351-FDB526E6-C4DC-454F-9F1D-7EF729217583 Q47229251-BE4B6BA0-70C4-439F-8F4B-6AD7EC7980BE Q47708298-4D954498-726D-4ADB-8EE7-2FD2CE8118B5 Q47744316-D9CB4E7A-F1F4-440E-B9AE-E3929D1F6AD6 Q48507796-ADB6F1C5-0A0A-4A24-925A-546AEDB02DA3 Q50233477-1127C323-6AFA-43E5-9ACA-BA1317784F20 Q55514888-AFD517BA-2F9C-49BD-B620-3E94C99BFCDD Q58728070-3AE405DD-FEA0-482A-B017-7732EABD4E53 Q59133957-5A19D0B4-0E8A-4D22-BCFE-CF7FCA3F6944

P2860

Resolvin D1 limits 5-lipoxygenase nuclear localization and leukotriene B4 synthesis by inhibiting a calcium-activated kinase pathway.

http://www.wikidata.org/entity/Q34407602

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Resolvin D1 limits 5-lipoxygen ...... cium-activated kinase pathway.

@ast

Resolvin D1 limits 5-lipoxygen ...... cium-activated kinase pathway.

@en

Resolvin D1 limits 5-lipoxygen ...... cium-activated kinase pathway.

@nl

type

label

Resolvin D1 limits 5-lipoxygen ...... cium-activated kinase pathway.

@ast

Resolvin D1 limits 5-lipoxygen ...... cium-activated kinase pathway.

@en

Resolvin D1 limits 5-lipoxygen ...... cium-activated kinase pathway.

@nl

prefLabel

Resolvin D1 limits 5-lipoxygen ...... cium-activated kinase pathway.

@ast

Resolvin D1 limits 5-lipoxygen ...... cium-activated kinase pathway.

@en

Resolvin D1 limits 5-lipoxygen ...... cium-activated kinase pathway.

@nl

P1433

Q34407602-7DB47F19-F53B-4CF1-A476-8DAD80CA6D95

P1476

Q34407602-687935DE-0D2A-408D-B745-6D1DC6B6E602

P2093

Q34407602-05B670B2-332B-440C-ABE0-AFF4B59D47F6

Q34407602-2BCFE255-DC97-4ECA-94C6-9932FB1653DF

Q34407602-595E102A-4BE0-494B-9BD2-1C67155B0900

Q34407602-5AEDF385-827B-4D4C-804B-D9D52C4166FA

Q34407602-7B1A16B8-EB29-4AE0-A143-E81AAFAC56B5

Q34407602-BB862EB8-9D89-4795-A9E6-322E7A89D8F3

P2860

Q34407602-012D8060-EDAA-4DCC-9069-3AE151842BF9

Q34407602-0849B6AB-1212-4DF0-A1D0-6EE313272285

Q34407602-2E73ACE0-E5B8-477D-9BD6-486B5B6ED9F8

Q34407602-39F3A1B2-EC96-46CE-B93F-8FC4283020D1

Q34407602-3AE5AC4A-7056-40F5-A20A-2821C8CE5810

Q34407602-43B21C21-8EBA-4310-8597-CE4E52FACD3F

Q34407602-4475BDCD-CA09-4EB5-BE16-006268B371B0

Q34407602-4752A80E-4A78-4D6D-970A-72F5E937D4BB

Q34407602-4A03D944-DAC1-4760-A2E3-49DA07A3441A

Q34407602-4EE1AE1E-CB01-4326-A604-EEA42414AD33

P304

Q34407602-DAF0FE94-B816-44A5-846F-17CBC9C76D77

P31

Q34407602-35B9A4D7-92A6-46C0-9A19-4349CDEAE059

P356

Q34407602-95341EDD-CF08-4044-927F-661769C13D6F

P407

Q34407602-5F819E90-1E78-4E81-9D2F-8F02E42451A2

P433

Q34407602-EA9A3D46-377C-40A4-AC14-F1F1E3720044

P478

Q34407602-D048B955-B924-4351-8399-FAA6C24CF36B

P50

Q34407602-B3F90F3B-6C05-4D4C-8DC9-8FD25EB8F41A

P577

Q34407602-7C5B6C31-F4F7-45E6-AD78-4C7288CE81E2

P5875

Q34407602-58E0DD7B-E27E-4527-9B93-29677B79E640

P698

Q34407602-2B8F067F-F985-401F-8D67-39374BCFCF6C

P921

Q34407602-5B70F43C-4986-4F9B-B95A-F9A8EA9FF1EB

P932

Q34407602-33B6E099-4AE4-4B6F-9EA6-DF36888174B0

P356

PNAS.1410851111

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Resolvin D1 limits 5-lipoxygen ...... lcium-activated kinase pathway

@en

P2093

Gabrielle Fredman

http://www.w3.org/2001/XMLSchema#string

Ira Tabas

http://www.w3.org/2001/XMLSchema#string

Jason Hellmann

http://www.w3.org/2001/XMLSchema#string

Johannes Backs

http://www.w3.org/2001/XMLSchema#string

Matthew Spite

http://www.w3.org/2001/XMLSchema#string

Stefano Spolitu

http://www.w3.org/2001/XMLSchema#string

P2860

5-lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes

Resolution of inflammation: an integrated view

Anti-inflammatory therapy in chronic disease: challenges and opportunities

Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis

Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease

Resolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci: receptor-dependent actions

Resolvin D1 binds human phagocytes with evidence for proresolving receptors

Translocation of 5-lipoxygenase to the membrane in human leukocytes challenged with ionophore A23187

Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor

Reversible, calcium-dependent membrane association of human leukocyte 5-lipoxygenase

P304

14530-14535

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1410851111

http://www.w3.org/2001/XMLSchema#string

P407

P433

40

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-09-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

267757168

http://www.w3.org/2001/XMLSchema#string

P698

25246560

http://www.w3.org/2001/XMLSchema#string

P921

P932

4210018

http://www.w3.org/2001/XMLSchema#string